Arterial lipiodolised chemotherapy [ethiodized oil + cisplatin] versus systemic chemotherapy with gemcitabine plus oxaliplatin (GEMOX) versus no treatment following surgical resection or local ablation of hepatocellular carcinoma in cirrhotic patients

Trial Profile

Arterial lipiodolised chemotherapy [ethiodized oil + cisplatin] versus systemic chemotherapy with gemcitabine plus oxaliplatin (GEMOX) versus no treatment following surgical resection or local ablation of hepatocellular carcinoma in cirrhotic patients

Discontinued
Phase of Trial: Phase III

Latest Information Update: 01 Jun 2011

At a glance

  • Drugs Cisplatin; Ethiodized oil; Gemcitabine; Oxaliplatin
  • Indications Liver cancer
  • Focus Therapeutic Use
  • Acronyms GEMOXIAL
  • Most Recent Events

    • 08 May 2011 Status changed from not yet recruiting to discontinued.
    • 16 May 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top